Associate Director, Medical Communications, EMEA

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.

As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.

 

The Associate Director, Medical Communications, EMEA will play a key role in executing regional medical communications initiatives across mainly Europe in alignment with the global medical and scientific strategy. Based in Europe and operating within a global matrix, this individual will partner closely with EMEA Medical Affairs, country medical teams, and cross-functional stakeholders to support the adaptation, localization, and implementation of global medical communications materials for healthcare professional (HCP) audiences. The role will support the phased expansion of our Medical Affairs Digital Resource Hub (MYO360) across Europe, beginning with Germany, execution of European congresses and medical symposia, and delivery of regionally relevant scientific communications that support the needs of EMEA Medical Affairs.